DXCM Dexcom Inc
8,022
$124.95
$2.10
(1.65%)
| Watchers | 8,022 |
| 52-Wk Low | $74.75 |
| 52-Wk High | $142.00 |
| Market Cap | $49.69B |
| Volume | 76.00 |
| 52-Wk High | $142.00 |
| 52-Wk Low | $74.75 |
Dexcom Beats First-Quarter Views And Raises Sales Outlook, But Shares Crumble...
DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended March 31, 2024. First Quarter 2024 Financial Highlights: Revenue grew 24% year-over-year to $921.0...
read more...
Latest Ratings for DXCM
DateFirmActionFromTo Feb 2022Morgan StanleyMaintainsEqual-Weight Feb 2022BTIGUpgradesNeutralBuy Jan 2022Wells FargoUpgradesEqual-WeightOverweight
View More Analyst...
Earnings season, which is fast approaching, is often somewhat volatile for the stock market. Companies that overdeliver or fail to deliver can see their share prices move significantly...
SteelPeak Wealth LLC reduced its position in DexCom, Inc. (NASDAQ:DXCM - Free Report) by 23.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange...
Mirae Asset Global Investments Co. Ltd. boosted its position in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) by 0.3% during the 4th quarter, according to its most recent 13F filing with the...
StockNews.com upgraded shares of DexCom (NASDAQ:DXCM - Free Report) from a hold rating to a buy rating in a research note released on Wednesday.
Several other brokerages have also recently issued...